LIANTONIO, ANTONELLA
 Distribuzione geografica
Continente #
NA - Nord America 5.294
EU - Europa 1.207
AS - Asia 700
SA - Sud America 24
OC - Oceania 4
AF - Africa 3
Totale 7.232
Nazione #
US - Stati Uniti d'America 5.275
CN - Cina 444
SE - Svezia 281
IT - Italia 259
SG - Singapore 186
UA - Ucraina 155
DE - Germania 116
FI - Finlandia 107
RU - Federazione Russa 89
GB - Regno Unito 75
FR - Francia 42
BE - Belgio 35
VN - Vietnam 27
IN - India 20
CA - Canada 18
BR - Brasile 16
CZ - Repubblica Ceca 15
IE - Irlanda 10
IR - Iran 10
NL - Olanda 9
HK - Hong Kong 5
CL - Cile 4
JP - Giappone 4
LT - Lituania 4
AU - Australia 3
DK - Danimarca 3
AR - Argentina 2
CH - Svizzera 2
LV - Lettonia 2
MA - Marocco 2
BD - Bangladesh 1
EC - Ecuador 1
EE - Estonia 1
ES - Italia 1
KE - Kenya 1
MX - Messico 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RO - Romania 1
TJ - Tagikistan 1
TR - Turchia 1
UY - Uruguay 1
Totale 7.232
Città #
Fairfield 738
Woodbridge 566
Chandler 439
Houston 386
Jacksonville 377
Ashburn 359
Cambridge 316
Seattle 285
Nyköping 247
Wilmington 241
Ann Arbor 232
Singapore 147
Bari 105
Lawrence 104
Roxbury 103
Nanjing 88
Princeton 82
Des Moines 65
Beijing 61
New York 61
Inglewood 60
Boardman 49
Jiaxing 36
San Diego 36
Brussels 35
Los Angeles 35
Nanchang 32
Dong Ket 27
Hebei 27
Shenyang 27
Milan 25
Falls Church 20
Santa Clara 18
Dearborn 16
Helsinki 16
London 16
Brno 15
Changsha 15
Guangzhou 15
Toronto 15
Shanghai 14
Paris 13
Pune 12
San Mateo 12
Dublin 10
Tianjin 10
Zhengzhou 10
Genova 9
Hefei 9
Monmouth Junction 9
Redwood City 9
Taranto 9
Ardabil 8
Augusta 8
Brooklyn 7
Leawood 7
Kunming 6
Washington 6
Grottaglie 5
Indiana 5
Jinan 5
Ningbo 5
Norwalk 5
Prescot 5
São Paulo 5
Wuhan 5
Campobello Di Mazara 4
Genoa 4
Grafing 4
Hong Kong 4
Marseille 4
San Francisco 4
Trani 4
Wuxi 4
Copenhagen 3
Frankfurt am Main 3
Fuzhou 3
Kilburn 3
Ottawa 3
Santa Marinella 3
Sennori 3
Acton 2
Altamura 2
Bollate 2
Brasília 2
Buenos Aires 2
Chongqing 2
Cisano Bergamasco 2
Como 2
Haikou 2
Harbin 2
Hounslow 2
Ksar el Kbir 2
Martina Franca 2
Mumbai 2
Naples 2
New Bedfont 2
Nulvi 2
Nuremberg 2
Riga 2
Totale 5.836
Nome #
ATP Sensitive Potassium Channels in the Skeletal Muscle Function: Involvement of the KCNJ11(Kir6.2) Gene in the Determination of Mechanical Warner Bratzer Shear Force 147
Effects of Nandrolone in the counteraction of skeletal muscle atrophy in a mouse model of muscle disuse: molecular biology and functional evaluation 142
Growth hormone secretagogues hexarelin and JMV2894 protect skeletal muscle from mitochondrial damages in a rat model of cisplatin-induced cachexia 142
Ion channels in drug discovery and safety pharmacology 133
Statin-induced myotoxicity is exacerbated by aging: A biophysical and molecular biology study in rats treated with atorvastatin 126
Antioxidant treatment of hindlimb-unloaded mouse counteracts fiber type transition but not atrophy of disused muscles 123
Elucidating the Contribution of Skeletal Muscle Ion Channels to Amyotrophic Lateral Sclerosis in search of new therapeutic options 121
Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy. 118
Activation and inhibition of kidney CLC-K chloride channels by fenamates 117
On the metabolically active form of metaglidasen: improved synthesis and investigation of its peculiar activity on peroxisome proliferator-activated receptors and skeletal muscles 115
Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia 110
Structural requisites of 2-(p-chlorophenoxy)propionic acid analogues for activity on native rat skeletal muscle chloride conductance and on heterologously expressed CLC-1 101
Carboxylic acids and skeletal muscle chloride channel conductance: Effects on the biological activity induced by the introduction of an aryloxyalkyl group α to the carboxylic function of 4-chloro-phenoxyacetic acid 101
null 99
Pharmacological characterization of chloride channels belonging to the ClC family by the use of chiral clofibric acid derivatives 98
Recovery of the soleus muscle after short- and long-term disuse induced by hindlimb unloading: effects on the electrical properties and myosin heavy chain profile 98
Alteration of excitation-contraction coupling mechanism in extensor digitorum longus muscle fibres of dystrophic mdx mouse and potential efficacy of taurine 97
Pre-clinical trials in Duchenne dystrophy: what animal models can tell us about potential drug effectiveness 96
Change of chloride ion channel conductance is an early event of slow-to-fast fibre type transition during unloading-induced muscle disuse 95
Fiber type-related changes in rat skeletal muscle calcium homeostasis during aging and restoration by growth hormone 93
null 93
Pharmacovigilance database search discloses ClC-K channels as a novel target of the AT1 receptor blockers valsartan and olmesartan 93
Taurine and skeletal muscle ion channels 91
null 90
The alteration of calcium homeostasis in adult dystrophic mdx muscle fibers is worsened by a chronic exercise in vivo 90
Identification of sites responsible for the potentiating effect of niflumic acid on ClC-Ka kidney chloride channels 87
null 87
Phosphorylation and IGF-1-mediated dephosphorylation pathways control the activity and the pharmacological properties of skeletal muscle chloride channels 86
Paracrine Effects of IGF-1 Overexpression on the Functional Decline Due to Skeletal Muscle Disuse: Molecular and Functional Evaluation in Hindlimb Unloaded MLC/mIgf-1 Transgenic Mice 84
A multidisciplinary evaluation of the effectiveness of cyclosporine A in dystrophic mdx mice 84
Niflumic acid inhibits chloride conductance of rat skeletal muscle by directly inhibiting the CLC-1 channel and by increasing intracellular calcium 83
Molecular determinants of differential pore blocking of kidney CLC-K chloride channels 80
Therapeutic approaches to genetic ion channelopathies and perspectives in drug discovery 77
JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia 77
Taurine and skeletal muscle disorders 75
New potent mexiletine and tocainide analogues evaluated in vivo and in vitro as antimyotonic agents on the myotonic ADR mouse 75
Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1 75
Involvement of Barttin Subunit in Pharmacological Potentiation of CLC-K Channels Expressed in Xenopus Oocytes 74
Gentamicin treatment in exercised mdx mice: Identification of dystrophin-sensitive pathways and evaluation of efficacy in work-loaded dystrophic muscle 74
Paving the way for Bartter syndrome type 3 drug discovery: a hope from basic research 73
Pharmacology of CLC chloride channels and transporters 72
Protein kinase C theta (PKCθ) modulates the ClC-1 chloride channel activity and skeletal muscle phenotype: a biophysical and gene expression study in mouse models lacking the PKCθ 72
Peptidic and Nonpeptidic Growth Hormone Secretagogues exert a protective effect on mitochondrial parameters analysed in a rat model of cachexia 71
Kidney CLC-K chloride channels inhibitors: structure-based studies and efficacy in hypertension and associated CLC-K polymorphisms. 71
null 70
Effect of HMG-CoA reductase inhibitors on excitation-contraction coupling of rat skeletal muscle 69
Investigations of pharmacologic properties of the renal CLC-K1 chloride channel co-expressed with barttin by the use of 2-(p-Chlorophenoxy)propionic acid derivatives and other structurally unrelated chloride channels blockers 68
Statins and fenofibrate affect skeletal muscle chloride conductance in rats by different impairing ClC-1 channel regulation and expression 68
null 68
Protein Kinase C-Theta Controls the CLC-1 Chloride Channel Function and Skeletal Muscle Phenotype: A Biophysical and Gene Expression Study in Pkc-Theta Null Mice 67
Potential targets for skeletal muscle impairment by hypogravity: basic characterization of resting ionic conductances and mechanical threshold of rat fast- and slow-twitch muscle fibers 66
Targeting kidney CLC-K channels: pharmacological profile in a human cell line versus Xenopus oocytes 65
Therapeutic approaches to ion channel diseases 64
Molecular switch for CLC-K Cl– channel block/activation: Optimal pharmacophoric requirements towards high-affinity ligands 64
Comparison of excitability parameters and sodium channel behavior of fast- and slow-twitch rat skeletal muscles for the study of the effects of hindlimb suspension, a model of hypogravity. 63
Investigating a Benzofurane Derivative Binding Site on Human CLC-5 63
Effect of rat hindlimb suspension on cable properties, ionic conductances and fiber type composition of slow-twitch muscle. 63
I-J loop involvement in the pharmacological profile of CLC-K channels expressed in Xenopus oocytes 63
Cisplatin-Induced Skeletal Muscle Dysfunction: Mechanisms and Counteracting Therapeutic Strategies 63
Growth hormone secretagogues exert differential effects on skeletal muscle calcium homeostasis in male rats depending on the peptidyl/non-peptidyl structure 62
Functional Study of Novel Bartter's Syndrome Mutations in ClC-Kb and Rescue by the Accessory Subunit Barttin Toward Personalized Medicine 62
Disuse of rat muscle in vivo reduces protein kinase C activity controlling the sarcolemma chloride conductance 60
Molecular determinants of 2(p-chlorophenoxy)propionic acid for modulation of the native chloride channel conductance of rat skeletal muscle 58
Decrease in resting calcium and calcium entry associated with slow-to-fast transition in unloaded rat soleus muscle 58
Antioxidant treatment of hindlimb-unloaded mouse in vivo counteracts fiber type transition but not atrophy of disused skeletal muscles 57
Calcium homeostasis is altered in skeletal muscle of spontaneously hypertensive rats cytofluorimetric and gene expression analysis 57
Potential benefits of taurine in the prevention of skeletal muscle impairment induced by disuse in the hindlimb-unloaded rat 56
Taurine and skeletal muscle ion channels 56
Molecular requisites for drug binding to muscle CLC-1 and renal CLC-K channel revealed by the use of phenoxy-alkyl derivatives of 2-(p-chlorophenoxy)propionic acid 56
Block of renal CLC-K channels by phenoxy-alkyl derivatives of clofibric acid 55
Kv1.1 channelopathies: Pathophysiological mechanisms and therapeutic approaches 55
Mechanism of Interaction of Niflumic Acid with Heterologously Expressed Kidney CLC-K Chloride Channels 54
Mechanism of block of single protopores of the Torpedo chloride channel ClC-0 by 2-(p-chlorophenoxy)butyric acid (CPB) 54
Age-dependent effects of disuse on electrophysiogical parameters and calcium homeostasis in the soleus muscle of hindlimb-unloaded mice 51
Potent effect of chiral derivative of mexiletine on rat skeletal muscle sodium channel 50
null 49
Gain-of-Function STIM1 L96V Mutation Causes Myogenesis Alteration in Muscle Cells From a Patient Affected by Tubular Aggregate Myopathy 49
Potent and stereoselective use-dependent block of skeletal muscle Na+ channels by a new proline-like tocainide derivative 47
Alteration of stim1/orai1-mediated soce in skeletal muscle: Impact in genetic muscle diseases and beyond 46
Mechanisms of block of muscle type CLC chloride channels 45
Farmaci per il trattamento delle malattie muscolari 45
null 45
In-vivo administration of CLC-K kidney chloride channels inhibitors increases water diuresis in rats: A new drug target for hypertension? 45
Niflumic acid derivatives modulate macroscopic chloride conductance of native rat skeletal muscle by inhibiting the CLC-1 channel and by increasing the intracellular calcium level 44
Increased sarcolemma chloride conductance as one of the mechanisms of action of carbonic anhydrase inhibitors in muscle excitability disorders 43
Taurine ameliorates in vitro and in vivo the electrical and contractile properties of skeletal muscle fibres of dystrophic mdx mouse 41
Role of tumour necrosis factor alpha, but not of cyclo-oxygenase-2-derived eicosanoids, on functional and morphological indices of dystrophic progression in mdx mice: a pharmacological approach 41
An olive oil-derived antioxidant mixture ameliorates the age-related decline of skeletal muscle function 40
On the mechanism of the interaction of niflumic acid with kidney CLC-K chloride channels 37
Investigation of human CLC-K kidney channel block by extracellular ligands 37
Pharmacology of chloride channels belonging to the CLC family 36
Independent impairment of chloride channel function and calcium homeostasis in dystrophic muscle of exercised MDX mouse 35
Inflammatory pathways and dystrophic progression: effect of in vivo treatment with either target-specific or wide-acting drugs on functional, biochemical and histological markers of muscle damage in exercised mdx mice 34
Skeletal muscle impairment during microgravity-induced disuse: Beneficial effects of different pharmacological countermeasures 32
Growth hormone secretagogues modulate the electrical an contractile properties of rat skeletal muscle through a ghrelin-specific receptor 31
A novel kcna2 variant in a patient with non-progressive congenital ataxia and epilepsy: Functional characterization and sensitivity to 4-aminopyridine 31
Evaluation of drug efficacy on muscular dystrophy by in vivo treatments in exercised mdx mouse 30
Clinical and Functional Study of a De Novo Variant in the PVP Motif of Kv1.1 Channel Associated with Epilepsy, Developmental Delay and Ataxia 26
Simulated microgravity modifies the activity of protein kinase C and serine-threonine phosphatase controlling the resting chloride channel conductance in skeletal muscle 26
Renal CLC-K chloride channels heterologously coexpressed with barttin are specifically affected by 2-(p-chlorophenoxy)propionic acid derivatives 26
Totale 7.052
Categoria #
all - tutte 35.274
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.274


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020836 0 0 0 0 0 0 197 147 218 83 144 47
2020/20211.196 140 61 80 99 107 35 92 65 113 193 133 78
2021/2022867 42 143 10 32 42 63 48 37 56 57 131 206
2022/20231.252 200 113 93 91 125 186 13 147 192 17 36 39
2023/2024494 31 79 26 64 50 106 24 20 5 36 7 46
2024/2025651 81 37 153 75 77 225 3 0 0 0 0 0
Totale 7.587